The disclosure provides compositions and methods for the detection of human papillomavirus (HPV) nucleic acids in a urine sample from a human subject. The nucleic acids may be from one or more high risk forms of HPV. The urine sample is minimally processed, without fractionation into cell-free and cell-containing portions, before preparation of the nucleic acids for detection of HPV sequences.
展开▼